|
STT3A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62481139653892E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.9146463848283E-13 |
| Normal-vs-Stage2 |
3.60520000000086E-05 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.67232894199287E-12 |
| Stage1-vs-Stage2 |
2.063400E-01 |
| Stage1-vs-Stage3 |
7.816000E-04 |
| Stage1-vs-Stage4 |
6.404500E-03 |
| Stage2-vs-Stage3 |
3.964300E-03 |
| Stage2-vs-Stage4 |
3.456100E-03 |
| Stage3-vs-Stage4 |
6.173400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
2.1343000000007E-05 |
| Normal-vs-Asian |
1.43969947075107E-10 |
| Caucasian-vs-AfricanAmerican |
2.567400E-01 |
| Caucasian-vs-Asian |
2.030800E-01 |
| AfricanAmerican-vs-Asian |
7.688600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
1.6618928455614E-12 |
| Male-vs-Female |
3.132100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.74849024148216E-12 |
| Normal-vs-Age(41-60Yrs) |
3.22075699443758E-13 |
| Normal-vs-Age(61-80Yrs) |
1.626032641866E-12 |
| Normal-vs-Age(81-100Yrs) |
3.70760000000248E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.634000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.712300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.067600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.489650E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.965400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.141200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.01130000040861E-07 |
| Classical-VS-Follicular |
1.038480E-02 |
| Classical-VS-Other |
1.633040E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
1.22909999955567E-08 |
| Tall-VS-Other |
6.097800E-01 |
| Tall-VS-Normal |
1.62436730732907E-12 |
| Follicular-VS-Other |
9.136000E-02 |
| Follicular-VS-Normal |
2.33379999999839E-05 |
| Other-VS-Normal |
1.98718999999681E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.1243994624266E-10 |
| Normal-vs-N1 |
2.99760216648792E-15 |
| N0-vs-N1 |
7.827500E-04 |
|
|
